Mackenzie, Isla

Professor, Professor

  • 2868 Citations
  • 24 h-Index
20022024
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Professor Isla Mackenzie MBChB (Honours), PhD, FRCP Edin, FBPharmacolS is a Professor of Cardiovascular Medicine and Honorary Consultant Physician at the University of Dundee and Ninewells Hospital, Dundee.  Research interests include cardiovascular safety of drugs, clinical trials, hypertension and technology in research.

Clinical interests include general medicine, hypertension and adrenal disorders including phaeochromocytoma. Professor Mackenzie trained in Clinical Pharmacology in Cambridge prior to moving to Dundee in 2008.

Teaching

Undergraduate teaching

  • Lectures, seminars, bedside teaching in Clinical Pharmacology/Therapeutics and Medicine (2000 - present)
  •  Marking and question writing for University of Dundee medical student examinations (2008 - present)
  • Medical School Interviews, University of Dundee (2011 - present) 
  • 5th year student portfolio reviewer, University of Dundee (2017- present)
  • Clinical Supervisor - MBPhD students (2000 - 2008)
  • Clinical Pharmacology college supervisions, Cambridge (2000 - 2004)
  • Clinical School Admission Interviews, University of Cambridge (2002 - 2008)

  •  BMSc Cardiovascular Medicine and Diabetes (2018

Postgraduate and multidisciplinary teaching

  • MRCP (PACES) teaching, Tayside (2012 -)
  • Educational / Clinical Supervisor, General Medicine trainees (2012 -)
  • Ward-based and clinical simulator teaching, Cambridge graduate course (2006 - 2008)

  • PASTEST Lecturer in Clinical Pharmacology, London (2005 - 2008)

  •  Bank Physician Trainer for GSK, Cambridge (2005 - 2008)

  •  Member of Clinical Pharmacology Training Committee, Cambridge (2000 - 2005)

  • Contributor to Clinical Pharmacology section of Medical Masterclass Website, Royal College of Physicians London / Blackwell Publishing (2003 -)

 

 

Research

My research focuses on improving cardiovascular outcomes and drug safety using a combination of large multicentre randomised clinical trials and pharmacoepidemiological approaches to answer important clinical research questions. I am also interested in clinical trial methodology and improving patient and physician engagement in clinical research. I am Chief Investigator of the ALL-HEART study (involving 424 GP sites and 5,938 patients) and Principal Investigator of other studies. I am Deputy Director of the MEMO Research Unit, University of Dundee with a team of >45 staff and >32,000 patients currently participating in our randomised clinical trials.

Research

Membership of learned societies

  •  British and Irish Hypertension Society (Fellow)
  • British Pharmacological Society (Fellow
  • Caledonian Society of Clinical Pharmacology
  •  Digital Health Institute
  •  International Society for Pharmacoepidemiology
  •  Royal College of Physicians Edinburgh (Fellow)
  •  Scottish Heart and Arterial disease Risk Prevention (SHARP) Group
  •  Scottish Society of Physician

 

Committee appointments and administrative roles

International:

Part of international consortium of stakeholders leading debate on investigative process into serious adverse outcomes in healthcare product research (2017-) 

National:

Sports Resolutions Panel of Arbitrators and Mediators. Specialist Member of National Anti-Doping Panel (2018-2021)

British Pharmacological Society Membership and Awards Committee (2016-)

British Pharmacological Society Clinical Committee (2016-)

Trustee of Scottish Heart and Arterial disease Risk Prevention (SHARP) Group (2015-)

Representative of the Faculty of Pharmaceutical Medicine on College Council, Royal College of Physicians Edinburgh (2014-2020)

Trustee on Faculty of Pharmaceutical Medicine Board (2014-2020)

Chief Medical Officer’s Specialty Adviser in Clinical Pharmacology (2013-2019)

British Hypertension Society Executive Committee (2012 - 2015). Trustee.

Scottish Society of Physicians Committee (2012 - present). Honorary Secretary of Scottish Society of Physicians (2013 – present)

Royal College of Physicians Edinburgh Symposium Committee (2012 - 2018) and Member of the Symposium Programme Development Panel, RCP Edinburgh (2012 - present)

British Hypertension Society Educational Programmes Working Party (2008 - 2015)

British and Irish Hypertension Society Collaborative Research Working Party (2014-present)

British Pharmacological Society Women in Pharmacology Committee (2007 - 2011)

Local:

Deputy Director of Medicines Monitoring Unit and Hypertension Research Centre

Member of MD/MSc Thesis Monitoring Committee, University of Dundee (2013 - present)

Member of Exceptional Medicine and Individual Medicine Requests Panel. Ninewells Hospital, Tayside NHS Trust. (2011 - 2015)

Elected Member of College of Medicine, Dentistry and Nursing College Board, University of Dundee (2013-2015)

Member of School of Medicine Equality, Diversity and Inclusion Committee (2016 - present)

Member of Medicines Monitoring Unit Information Security Forum (2016-present)

Reviewer of potential REF outputs, Molecular and Clinical Medicine (2017, 2018)

Member of School of Medicine Research Management Group (2017-present)

Member of North of Scotland Familial Hypercholesterolaemia Steering Group (2017- present)

Deputy PhD Lead for Division of Molecular and Clinical Medicine, School of Medicine (2018 – present)

Regularly sit on interview panels for University of Dundee/NHS appointments

 

Trial Steering Committees:

Standard care versus Celecoxib Outcome Trial (SCOT)

Febuxostat versus Allopurinol Streamlined Trial (FAST)

Prevention And Treatment of Resistant Hypertension With Algorithm based TherapY (PATHWAY) 1, 2 and 3 – University of Cambridge, Cambridge (BHF)

Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL-HEART)

Treatment in the Morning vs the Evening study (TIME)

Lowering Events in Non-proliferative retinopathy in Scotland (LENS), University of Oxford, Oxford

 

Keywords

  • R Medicine (General)
  • pharmacoepidemiology
  • Drug Safety
  • randomised clinical trials
  • clinical trial methodology
  • cardiovascular outcomes

Fingerprint Dive into the research topics where Isla Mackenzie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 33 Similar Profiles
Allopurinol Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences
Hypertension Medicine & Life Sciences
Spironolactone Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Celecoxib Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2024

Research Output 2002 2019

50 Downloads (Pure)
Open Access
File
Allopurinol
Clinical Trials
Random Allocation
Gout
Registries
1 Citation (Scopus)
55 Downloads (Pure)
Open Access
File
24 Citations (Scopus)
32 Downloads (Pure)

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., Mackenzie, I. S., Salsbury, J. & Brown, M. J., 1 Jun 2018, In : The Lancet Diabetes and Endocrinology. 6, 6, p. 464-475 12 p.

Research output: Contribution to journalArticle

Open Access
File
Spironolactone
Amiloride
Hemodynamics
Blood Pressure
Hypertension
88 Downloads (Pure)

Ibuprofen and Paracetamol: Acceptably Safe for All?

Pigazzani, F., Mackenzie, I. & MacDonald, T. M., Nov 2018, In : Drug Safety. 41, 11, p. 999-1001 3 p.

Research output: Contribution to journalComment/debate

Open Access
File
13 Downloads (Pure)
Open Access
File
Sleep
Randomized Controlled Trials
Antihypertensive Agents
Therapeutics
Stroke

Activities 2012 2012

  • 1 Editorial activity
  • 1 Membership of committee

British Journal of Clinical Pharmacology (Journal)

Isla S. Mackenzie (Editor)
1 Jan 20121 Jan 2015

Activity: Publication peer-review and editorial work typesEditorial activity

British Hypertension Society (External organisation)

Isla S. Mackenzie (Member)
20122015

Activity: Membership typesMembership of committee

Press / Media